Design and analysis considerations for comparing dynamic treatment regimens with binary outcomes from sequential multiple assignment randomized trials

References

• A. Agresti, Categorical Data Analysis, John Wiley & Sons, Hoboken, NJ, 2013.
   Google Scholar
• D. Almirall, S.N. Compton, M. Gunlicks-Stoessel, N. Duan, and S.A. Murphy, Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy, Stat. Med. 31 (2012), pp. 1887–1902. doi: 10.1002/sim.4512
   PubMed Web of Science ®Google Scholar
• D. Almirall, C. DiStefano, Y.C. Chang, S. Shire, A. Kaiser, X. Lu, I. Nahum-Shani, R. Landa, P. Mathy, and C. Kasari, Longitudinal effects of adaptive interventions with a speech-generating device in minimally verbal children with ASD, J. Clin. Child. Adolesc. Psychol. 35 (2016), pp. 1595–1615.
   Google Scholar
• D. Almirall, I. Nahum-Shani, N. Sherwood, and S. Murphy, Introduction to smart designs for the development of adaptive interventions: With application to weight loss research, Transl. Behav. Med. 4 (2014), pp. 260–274. doi:10.1007/s13142-014-0265-0.
   PubMed Web of Science ®Google Scholar
• S.F. Auyeung, Q. Long, E.B. Royster, S. Murthy, M.D. McNutt, D. Lawson, A. Miller, A. Manatunga, and D.L. Musselman, Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy, Clin. Trials 6 (2009), pp. 480–490. doi: 10.1177/1740774509344633
   PubMed Web of Science ®Google Scholar
• O. Bembom and M.J. van der Laan, Statistical methods for analyzing sequentially randomized trials, J. Natl. Cancer Inst. 99 (2007), pp. 1577–1582. doi: 10.1093/jnci/djm185
   PubMedGoogle Scholar
• O. Bembom and M.J. van der Laan, Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules, Stat. Med. 27 (2008), pp. 3689–3716. doi: 10.1002/sim.3268
   PubMed Web of Science ®Google Scholar
• M. Campbell, S. Julious, and D. Altmani, Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons, Br. Med. J. 311 (1995), pp. 1145–1148. doi: 10.1136/bmj.311.7013.1145
   PubMed Web of Science ®Google Scholar
• L. Collins, S. Murphy, and K. Bierman, A conceptual framework for adaptive preventive interventions, Prev. Sci. 5 (2004), pp. 185–196. doi: 10.1023/B:PREV.0000037641.26017.00
   PubMed Web of Science ®Google Scholar
• R. Dawson and P. Lavori, Sample size calculations for evaluating treatment policies in multi-stage designs, Clin. Trials 7 (2010), pp. 643–652. doi: 10.1177/1740774510376418
   PubMed Web of Science ®Google Scholar
• E. Demidenko, Sample size determination for logistic regression revisited, Stat. Med. 26 (2007), pp. 3385–3397. doi:10.1002/sim.2771.
   PubMed Web of Science ®Google Scholar
• E. Demidenko, Sample size and optimal design for logistic regression with binary interaction, Stat. Med. 27 (2008), pp. 36–46. doi: 10.1002/sim.2980
   PubMed Web of Science ®Google Scholar
• A. Ertefaie, K. Deng, A.T. Wagner, and S.A. Murphy, qlaci R package for using q-learning to construct adaptive interventions using data from a SMART (Version 1.0) (2014). Available at methodology.psu.edu, The Methodology Center, Penn State, University Park.
   Google Scholar
• W. Feng and A.S. Wahed, Supremum weighted log-rank test and sample size for comparing two-stage adaptive treatment strategies, Biometrika 95 (2008), pp. 695–707. doi: 10.1093/biomet/asn025
   Web of Science ®Google Scholar
• M.R. Kosorok and E.E.M. Moodie (eds.), Adaptive Treatment Strategies in Practice: Planning Trials and Analyzing Data for Personalized Medicine, ASA-SIAM Series on Statistics and Applied Probability, SIAM, Philadelphia, ASA, Alexandria, VA, 2016.
   Google Scholar
• T. Habermann, E. Weller, V. Morrison, R. Gascoyne, P. Cassileth, J. Cohn, S. Dakhil, B. Woda, R. Fisher, B. Peterson, and S. Horning, Rituximab-CHOP verses CHOP alone or with maintenance Rituximab in older patients with diffuse large B-cell lymphoma, J. Clin. Oncol. 24 (2006), pp. 3121–3127. doi: 10.1200/JCO.2005.05.1003
   PubMed Web of Science ®Google Scholar
• M. Hernán, B. Brumback, and J. Robins, Marginal structural models to estimate the causal effect of zidovudine on the survival of hiv-positive men, Epidemiology 11 (2000), pp. 561–570. doi: 10.1097/00001648-200009000-00012
   PubMed Web of Science ®Google Scholar
• S.T. Holloway, E.B. Laber, K.A. Linn, B. Zhang, M. Davidian, and A.A. Tsiatis, DynTxRegime: Methods for estimating dynamic treatment regimes (2015). Available at https://CRAN.R-project.org/package=DynTxRegime, R package version 2.1.
   Google Scholar
• H.E. Jones, K.E. O'Grady, and M. Tuten, Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment, The American Journal on Addictions 20 (2011), pp. 196–204. doi:10.1111/j.1521-0391.2011.00119.x.
   PubMed Web of Science ®Google Scholar
• C. Kasari, A. Kaiser, K. Goods, J. Nietfeld, P. Mathy, R. Landa, S. Murphy, and D. Almirall, Communication interventions for minimally verbal children with autism: A sequential multiple assignment randomized trial, J. Am. Acad. Child. Adolesc. Psychiatry. 53 (2014), pp. 635–646. Available at http://www.sciencedirect.com/science/article/pii/S08908567140%01634. doi: 10.1016/j.jaac.2014.01.019
   PubMed Web of Science ®Google Scholar
• A. Kilbourne, D. Almirall, D. Eisenberg, J. Waxmonsky, D. Goodrich, J. Fortney, J. Kircher, L. Solberg, M. Main, J. Kyle, S. Murphy, K. Nord, and M. Thomas, Protocol: Adaptive implementation of effective programs trial (adept): cluster randomized smart trial comparing a standard versus enhanced implementation strategy to improve outcomes of a mood disorders program, Implement. Sci. 9 (2014), pp. 132. doi: 10.1186/s13012-014-0132-x
   PubMed Web of Science ®Google Scholar
• P.W. Lavori and R. Dawson, A design for testing clinical strategies: Biased individually tailored within-subject randomization, J. R. Statist. Soc. A 163 (2000), pp. 29–38. doi: 10.1111/1467-985X.00154
   Web of Science ®Google Scholar
• P.W. Lavori, R. Dawson, and A.J. Rush, Flexible treatment strategies in chronic disease: Clinical research implications, Biol. Psychol. 48 (2000), pp. 605–614. doi: 10.1016/S0006-3223(00)00946-X
   Web of Science ®Google Scholar
• P.W. Lavori, R. Dawson, and A.J. Rush, Dynamic treatment regimes: Practical design considerations, Clin. Trials 1 (2004), pp. 9–20. doi: 10.1191/1740774S04cn002oa
   PubMedGoogle Scholar
• H. Lei, I. Nahum-Shani, K. Lynch, D. Oslin, and S.A. Murphy, A ‘SMART’ design for building individualized treatment sequences, Annu. Rev. Clin. Psychol. 8 (2012), pp. 21–48. doi: 10.1146/annurev-clinpsy-032511-143152
   PubMed Web of Science ®Google Scholar
• Z. Li and S.A. Murphy, Sample size formulae for two-stage random trials with survival outcomes, Biometrika 98 (2011), pp. 503–518. doi: 10.1093/biomet/asr019
   PubMed Web of Science ®Google Scholar
• X. Lu, I. Nahum-Shani, C. Kasari, D.W. Oslin, W.E. Pelham, G. Fabiano, and D. Almirall, Comparing dynamic treatment regimes using repeated-measures outcomes: Modeling considerations in smart studies, Stat. Med. 45 (2016), pp. 442–456.
   Google Scholar
• K.A. Lynn, E.B. Laber, and L.A. Stefanski, iqlearn: Interactive q-learning in r, J. Stat. Softw. 64 (2015), pp. 1–25.
   Web of Science ®Google Scholar
• M.V. Mateos, A. Orio, J. Martínez-López, N. Gutiérrez, A.I. Teruel, R. de Paz, J. García-Lara na, E. Bengoechea, A. Martín, J.D. Mediavilla, L. Palomera, F. de Arriba, Y. González, J.M. Hernández, A. Sureda, J.L. Bello, J. Bargay, F.J. Peñalver, J.M. Ribera, M.L. Martín-Mateos, R. García-Sanz, M.T. Cibeira, M.L.M. Ramos, M.B. Vidriales, B. Paiva, M.A. Montalbán, J.J. Lahuerta, J. Bladé, and J.F.S. Miguel, Bortezomib, melphalan, and prednisone versus Bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with Bortezomib and thalidomide versus Bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial, Lancet Oncol 11 (2010), pp. 934–941. doi: 10.1016/S1470-2045(10)70187-X
   PubMed Web of Science ®Google Scholar
• K.K. Matthay, C.P. Reynolds, R.C. Seeger, H. Shimada, E.S. Adkins, D. Haas-Kogan, R.B. Gerbing, W.B. London, and J.G. Villablanca, Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children's oncology group study, J. Clin. Oncol. 27 (2009), pp. 1007–1013. doi: 10.1200/JCO.2007.13.8925
   PubMed Web of Science ®Google Scholar
• K.K. Matthay, J.G. Villablanca, R.C. Seeger, D.O. Stram, R.E. Harris, N.K. Ramsay, P. Swift, H. Shimada, C.T. Black, G.M. Brodeur, R.B. Gerbing, and C.P. Reynolds, Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid, N. Engl. J. Med. 341 (1999), pp. 1165–1173. doi: 10.1056/NEJM199910143411601
   PubMed Web of Science ®Google Scholar
• S. Murphy, An experimental design for the development of adaptive treatment strategies, Stat. Med. 24 (2005), pp. 1455–1481. doi: 10.1002/sim.2022
   PubMed Web of Science ®Google Scholar
• S. Murphy and D. Almirall, Dynamic treatment regimens, in Encyclopedia of Medical Decision Making, M.W. Kattan, ed., Sage Publications, Thousand Oaks, CA, 2009, pp. 419–422.
   Google Scholar
• S.A. Murphy, M.J. van der Laan, J.M. Robins, and CPPRG, Marginal mean models for dynamic regimes, J. Am. Stat. Assoc. 96 (2001), pp. 1410–1423. doi: 10.1198/016214501753382327
   PubMed Web of Science ®Google Scholar
• I. Nahum-Shani, M. Qian, D. Almirall, W. Pelham, B. Gnagy, G. Fabiano, J. Waxmonsky, J. Yu, and S. Murphy, Experimental design and primary data analysis for developing adaptive interventions, Psychol. Methods 17 (2012), pp. 457–477. doi: 10.1037/a0029372
   PubMed Web of Science ®Google Scholar
• A.I. Oetting, J.A. Levy, R.D. Weiss, and S.A. Murphy, Statistical methodology for a SMART design in the development of adaptive treatment strategies, in Causality and Psychopathology: Finding the Determinants of Disorders and their Cures, P. Shrout, K. Keyes, and K. Ornstein, eds., Chapter 8, American Psychopathological Association, American Psychiatric Publishing, Inc., Arlington, VA, 2011, pp. 179–205.
   Google Scholar
• S.B. Ogbagaber, J. Karp, and A.S. Wahed, Design of sequentially randomized trials for testing adaptive treatment strategies, Stat. Med. 35 (2016), pp. 840–858. doi: 10.1002/sim.6747.
   PubMed Web of Science ®Google Scholar
• L. Orellana, A. Rotnitzky, and J. Robins, Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, part i: Main content, Int. J. Biostat. 6 (2010), pp. 8.
   PubMedGoogle Scholar
• D. Oslin, Managing alcoholism in people who do not respond to naltrexone (EXTEND). Available at http://clinicaltrials.gov/ct2/show/NCT00115037?term=oslin&rank=8 (2005).
   Google Scholar
• W. Pelham and G. Fabiano, Evidence-based psychosocial treatments for attention-deficit/ hyperactivity disorder, J. Clin. Child. Adolesc. Psychol. 37 (2008), pp. 184–214. doi: 10.1080/15374410701818681
   PubMed Web of Science ®Google Scholar
• J. Robins, A new approach to causal inference in mortality studies with sustained exposure periods- application to control of the healthy worker survivor effect., Math. Model. 7 (1986), pp. 1393–1512. doi: 10.1016/0270-0255(86)90088-6
   Web of Science ®Google Scholar
• J.M. Robins, Association, causation, and marginal structural models, Synthese 121 (1999), pp. 151–179. doi: 10.1023/A:1005285815569
   Web of Science ®Google Scholar
• S.M. Shortreed, E. Laber, T. Scott Stroup, J. Pineau, and S.A. Murphy, A multiple imputation strategy for sequential multiple assignment randomized trials, Stat. Med. 33 (2014), pp. 4202–4214. doi:10.1002/sim.6223.
   PubMed Web of Science ®Google Scholar
• R.M. Stone, D.T. Berg, S.L. George, R.K. Dodge, P.A. Paciucci, P.P. Schulman, E.J. Lee, J.O. Moore, B.L. Powell, M.R. Baer, C.D. Bloomfield, and C.A. Schiffer, Postremission therapy in older patients with de novo acute myeloid leukemia: A randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine, Blood 98 (2001), pp. 548–53. doi: 10.1182/blood.V98.3.548
   PubMed Web of Science ®Google Scholar
• R.M. Stone, D.T. Berg, S.L. George, R.K. Dodge, P.A. Paciucci, P.P. Schulman, E.J. Lee, J.O. Moore, B.L. Powell, M.R. Baer, and C.A. Schiffer, Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia, N. Engl. J. Med. 332 (1995), pp. 1671–1677. doi: 10.1056/NEJM199506223322503
   PubMed Web of Science ®Google Scholar
• X. Tang and M. Melguizo, DTR: An R package for estimation and comparison of survival outcomes of dynamic treatment regimes, J. Stat. Softw. 65 (2015), pp. 1–28. Available at http://www.jstatsoft.org/v65/i07/. doi: 10.18637/jss.v065.i07
   Web of Science ®Google Scholar
• D. Tummarello, D. Mari, F. Graziano, P. Isidori, G. Cetto, F. Pasini, A. Santo, and R. Cellerino, A randomized, controlled phase iii study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T),followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses, Cancer 80 (1997), pp. 2222–2229. doi: 10.1002/(SICI)1097-0142(19971215)80:12<2222::AID-CNCR2>3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• M. Wallace, E. Moodie, and D. Stephens, Dynamic treatment regimen estimation via regression-based techniques: Introducing r package dtrreg, Journal of Statistical Software (2016) (accepted).
   Google Scholar
• J. Xin, B. Chakraborty, and E.B. Laber, qLearn: Estimation and inference for Q-learning (2012). Available at https://CRAN.R-project.org/package=qLearn, R package version 1.0.
   Google Scholar
• Y. Zhang, listdtr: List-Based Rules for Dynamic Treatment Regimes (2016). Available at https://CRAN.R-project.org/package=listdtr, R package version 1.0.
   Google Scholar
• S.L. Zeger, K-Y. Liang, and P.S. Albert, Models for longitudinal data: A generalized estimating equation approach, Biometrics 44 (1988), pp. 1049–1060. Available at http://www.jstor.org/stable/2531734. doi: 10.2307/2531734
   PubMed Web of Science ®Google Scholar